Antimicrobial peptides: On future antiprotozoal and anthelminthic applications

Acta Trop. 2022 Nov:235:106665. doi: 10.1016/j.actatropica.2022.106665. Epub 2022 Aug 24.

Abstract

Control and elimination of parasitic diseases are nowadays further complicated by emergence of drug resistance. Drug resistance is a serious threat as there are not many effective antiparasitic drugs available. Aside from drug resistance, it is also favorable to look for alternative therapeutics that have lesser adverse effects. Antimicrobial peptides (AMPs) were found to address these issues. Some of its desirable traits are they are fast-acting, it has broad action that the pathogen will have difficulty developing resistance to, it has high specificity, and most importantly there are extensive sources such as bacteria; invertebrate and vertebrate animals as well as plants. Aside from this, AMPs are also found to modulate the immune response. This review would like to describe AMPs that have been studied for their antiparasitic activities especially on parasitic diseases that causes high mortality and exhibits drug resistance like malaria and leishmaniasis and to discuss the mechanism of action of these AMPS.

Keywords: Antimicrobial peptides (AMPs); Drug resistance; Parasitic diseases.

Publication types

  • Review

MeSH terms

  • Animals
  • Anthelmintics* / pharmacology
  • Antimicrobial Cationic Peptides / pharmacology
  • Antimicrobial Cationic Peptides / therapeutic use
  • Antimicrobial Peptides
  • Antiparasitic Agents / pharmacology
  • Antiparasitic Agents / therapeutic use
  • Antiprotozoal Agents* / pharmacology
  • Antiprotozoal Agents* / therapeutic use
  • Bacteria

Substances

  • Anthelmintics
  • Antimicrobial Cationic Peptides
  • Antimicrobial Peptides
  • Antiparasitic Agents
  • Antiprotozoal Agents